Heart disease in older women: Gender differences affect diagnosis and treatment

Geriatrics

Volumn 58, Issue 12, 2003, Pages 33-40

  Tecce, Marc A ^a   Dasgupta, Indranil ^a   Doherty, John U ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Gender; Heart disease; Risk factor; Women

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; TIROFIBAN;

ANGIOPLASTY; BLEEDING; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL DISEASE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; NAUSEA; PEPTIC ULCER; PREVALENCE; REVIEW; SEX DIFFERENCE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; FEMALE; HEALTH BEHAVIOR; HEART DISEASES; HUMANS; MIDDLE AGED; RISK FACTORS; SEX FACTORS; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 0345098397     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. American Heart Association. Heart disease and stroke statistics-2003 update. Dallas. TX: American Heart Association; 2002.
2. Kannel WB. Abbott RD. Incidence and prognosis of myocardial infarction in women: The Framingham Study. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA (eds). Coronary heart disease in women. New York: Haymarket-Doyma, 1987; 208:14.
3. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham Study. Prognosis and survival. Am J Cardiol 1972: 29(2):154-63.
4. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: A 20-year population-based perspective (1975-1995). Am J Cardiol 1998: 82(11):1311-7.
5. White HD, Barbash GI, Califf RN, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation 1996; 94(8):1826-33.
6. Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: A report from the TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997; 30(1):141-8
7. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ, Women's early warning symptoms of acute myocardial infarction. Circulation 2003: 108. Published online before print November 3, 2003. Accessed at http://circ.ahajournals.org on November 4, 2003.
8. Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: Adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9(3):473-82.
9. Jenkins JS, Flaker GC, Nolte B, et al. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol 1994: 73(5):319-22.
10. Hamilton GA. Recovery from acute myocardial infarction in women. Cardiology 1990; 77 (Suppl 2):58-70.
11. Gibbons RJ, Fyke FE III, Clements IP, Lapeyre AC III, Zinsmeister AR, Brown ML. Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography. J Am Coll Cardiol 1988; 11(1):28-34.
12. Santos Ocampo CD, Herman SD, Travin MI, et al. Comparison of exercise, dipyridamole and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1994; 1(1):57-64
13. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: An effect of smaller chamber size. J Am Coll Cardiol 1996; 28(5):1214-9.
14. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83(5):660-6.
15. Chen G, Redberg RF. Noninvasive diagnostic testing of coronary artery disease in women. Cardiol Rev 2000; 8(6):354-60.
16. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995; 26(2):335-41.
17. Gruppo Italiano per lo Studio Della Streptokinase nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1(8478):397-402.
18. ISIS 2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2(8607):349-60.
19. Woodfield SL, Lundergan CF, Reiner JS, et al. Gender and acute myocardial infarction: Is there a different response to thrombolysis? J Am Coll Cardiol 1997; 29(1):35-42.
20. White HD, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation 1993: 88(5 Pt 1):2097-103.
21. Lincoff AM, Califf RM, Ellis SG, et al. Thrombolytic therapy for women with myocardial infarction: Is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993; 22(7):1780-7.
22. Becker RC, Terrin M, Ross R, et al. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med 1994; 120(8):638-45.
23. Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA registry. Circulation 1985; 71(1):90-7.
24. Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74(1):18-21.
25. Weintraub WS, Wenger NK, Kosinski AS, et al. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol 1994; 24(1):82-90.
26. Grines CI, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328(10):673-9.
27. Ghali WA, Faris PD, Galbraith D, et al. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Sex differences in access to coronary revascularization after cardiac catheterization: Importance of detailed clinical data. Ann Intern Med 2002; 136(10):723-32.
28. Feldman T, Silver R. Gender differences and the outcome of interventions for acute coronary syndromes. Cardiol Rev 2000; 8(4):240-7.
29. Weintraub WS, Wenger NK, Jones EL, Craver SM, Guyton RA. Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation 1993; 88(5 Pt 2): 1179-86.
30. Aldea GS, Gaudiani JM, Shapira OM, et al. Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. Ann Thorac Surg 1999; 67(4):1097-103.
31. Fisher LD, Kennedy JW, Davis KB, et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982; 84(3):334-41.
32. Rahimtoola SH, Bennett AJ, Grunkemeier GL, Block P, Starr A. Survival at 15 to 18 years after coronary bypass surgery for angina in women. Circulation 1993; 88(5 Pt 2):1171-8.
33. Denke MA: Primary prevention of coronary heart disease in postmenopausal women. Am J Med 1999; 207 (2A):48S-50S.
34. LaRosa JC. Triglycerides and coronary risks in women and the elderly. Arch Intern Med 1997; 157(9):961-8.
35. Lewis SJ, Sacks FM, Mitchell JS, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial. J Am Coll Cardiol 1998; 32(11):140-6.
36. Shlipak MG, Simon JA, Vittinghoff E, et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 2000; 283(14):1845-52.
37. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) research group. JAMA 1998; 280(7):605-13.
38. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288(3):321-33.
39. Herrington DM, Vittinghoff E, Lin F, et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002: 105(25):2962-7.
40. Howard BV, Conway LD, Hatner SM. Women, diabetes, lipoproteins and the risks for coronary heart disease. In: Forte TM (ed). Hormonal, metabolic and cellular influences on cardiovascular disease in women. Armonk/New York: Futura Publishing Company, 1997:S262.
41. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risks by use of multiple risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100(13):1481-92.
42. Jousilahti P, Vartiamen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors and coronary heart disease: A prospective follow-up study of 14.786 middle-aged men and women in Finland. Circulation 1999; 99(9):1265-72.
43. Bittner V, Oparil S. Hypertension. In: Douglas PS (ed). Cardiovascular health and disease in women. Philadelphia: Saunders, 1993:63.
44. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265(24):3255-64.